Journal
Blood Advances
Publication Date
1-25-2023
Volume
7
Issue
3
First Page
302
Last Page
308
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2022007340
Rights and Permissions
Doherty D, Michelle Lavin, Byrne M, Nolan M, O'Sullivan JM, Ryan K, O'Connell NM, Haberichter SL, Christopherson PA, Di Paola J, James PD, O'Donnell JS. Enhanced VWF clearance in low VWF pathogenesis: limitations of the VWFpp/VWF:Ag ratio and clinical significance. Blood Adv. 2023 Feb 14;7(3):302-308. doi: 10.1182/bloodadvances.2022007340. © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Doherty, Dearbhla; Michelle Lavin; Byrne, Mary; Nolan, Margaret; O'Sullivan, Jamie M; Ryan, Kevin; O'Connell, Niamh M; Haberichter, Sandra L; Christopherson, Pamela A; Di Paola, Jorge; James, Paula D; and O'Donnell, James S, "Enhanced VWF clearance in low VWF pathogenesis: Limitations of the VWFpp/VWF:Ag ratio and clinical significance." Blood Advances. 7, 3. 302 - 308. (2023).
https://digitalcommons.wustl.edu/oa_4/1648
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
